Michel Belieres

Title: Michel Belieres: Innovator in Thorium Production

Introduction

Michel Belieres is a notable inventor based in Limoges, France. He has made significant contributions to the field of nuclear medicine through his innovative processes. His work focuses on the production of thorium-228, which has important applications in the medical field.

Latest Patents

Michel Belieres holds a patent for the "Production of thorium 228 starting from a natural thorium salt." This invention outlines a process that involves several steps. First, it includes the separation of radium from other radioelements present in the natural thorium salt. This is achieved through coprecipitation with barium sulfate. The process further involves the extraction of thorium-228 from the coprecipitate, which is derived from the decay of radium-228. Additionally, there is an optional step for the purification and concentration of the extracted thorium-228. The applications of this invention are particularly relevant in the manufacture of radiopharmaceutical products, which are useful in nuclear medicine, especially in radioimmunotherapy for treating cancers and AIDS.

Career Highlights

Michel Belieres is associated with Areva NC, a company known for its advancements in nuclear technology. His work has contributed to the development of innovative solutions in the field of radiopharmaceuticals.

Collaborations

He has collaborated with notable colleagues such as Gilbert Andreoletti and Pascal Nardoux. Their combined expertise has furthered the advancements in the processes related to thorium production.

Conclusion

Michel Belieres stands out as an inventor whose work in thorium production has significant implications for nuclear medicine. His innovative processes pave the way for advancements in cancer treatment and other medical applications.